Dow Up 0.76% Nasdaq Up 0.69%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
8.33 0.00(0.00%) Oct 24, 3:59PM EDT
Prev Close:8.33
Open:8.34
Bid:N/A
Ask:9.70 x 2500
1y Target Est:7.67
Beta:0.65
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:8.17 - 8.60
52wk Range:7.22 - 10.26
Volume:3,254,624
Avg Vol (3m):3,179,260
Market Cap:1.34B
P/E (ttm):5.04
EPS (ttm):1.65
Div & Yield:0.60 (7.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLI 0.00%1.34B
AMGNUp 0.01%111.86B
SGENUp 0.98%4.44B
XOMADown 1.60%460.43M

Key Statistics

Forward P/E (1 yr):3.44
P/S (ttm):3.05
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :2.20
Quarterly EPS Est (Sep-14) :0.61
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback